申请人:FibroGen, Inc.
公开号:US08324405B2
公开(公告)日:2012-12-04
The present invention relates to novel compounds of formula (I), methods, and compositions capable of decreasing HIF hydroxylase activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
本发明涉及公式(I)的新化合物,方法和组合物,能够降低HIF羟化酶活性,从而增加缺氧诱导因子(HIF)的稳定性和/或活性。